DOI: http://dx.doi.org/10.18203/2349-3933.ijam20195611

Study of hematological profile in patients with chronic kidney disease

Gautam Panduranga, Ugendhar Perla

Abstract


Background: Chronic Kidney Disease (CKD) with its high prevalence, morbidity and mortality, has become an important public health problem. The incidence and prevalence of CKD is increasing worldwide, including India. CKD is associated with a variety of hematological abnormalities, include anaemia, infections and bleeding diathesis. Anaemia is the most consistent hematological abnormality and is associated with poor quality of life and poor cardiovascular outcomes.

Methods: A hospital based cross-sectional observational study was done to detect the prevalence of haematological abnormalities, correlation of anaemia with CKD stage and evaluation of iron deficiency. Newly diagnosed CKD (stages 3 to 5) patients were included in this study. Presence of anaemia (Hb%, haematocrit, MCV, peripheral smear), iron deficiency (TSAT, serum ferritin), thrombocytopenia, leucocyte count and coagulation abnormalities (PT, APTT) in different stages of CKD were studied.

Results: All the subjects in study group had anaemia which was normocytic and normochromic and of moderate degree in most patients. The severity of anaemia progressed with stage of the disease. Iron deficiency was significantly prevalent (52% in the study population, with transferrin saturation (TSAT) <20%). WBC count was not significantly altered. There was mild thrombocytopenia in a few patients. Bleeding time or other in vitro tests of platelet function were not measured. The coagulation parameters, PT and APTT, were not significantly altered.

Conclusions: All CKD patients should be screened for iron deficiency anaemia for its early treatment and to decrease morbidity.


Keywords


Anaemia in CKD, Chronic kidney disease, Haematological abnormalities in CKD, Iron deficiency anaemia, Transferrin saturation, Thrombocytopenia

Full Text:

PDF

References


Roger SD. Managing the anaemia of chronic kidney disease. Australian Prescr. 2009 Oct 1;32(5):129-31.

Abdu A, Arogundade F, Adamu B, Dutse AI, Sanusi A, Sani MU, et al. Anaemia and its response to treatment with recombinant human erythropoietin in chronic kidney disease patients. West African J Med. 2009; 28(5).

KDOQI, National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006 May;47:S11-5.

Анемії К. Kdigo clinical practice guideline for anemia in chronic kidney disease. Kidney Inter Suppl. 2012;2(4):283-7.

Chakravarti A, Ukey A, Bajaj P, Saragade P. A Study of Hematological Profile in Patients of Chronic Renal Failure Undergoing Hemodialysis at a Tertiary Health Care Institute. MVP J Med Sci. 2017 Dec 14;4(2):107-12.

Dewan P, Patil N, Bharti M. Hematological profile in cases of chronic renal diseases. IOSR J Dent Med Sci. 2017;16(4):1-3.

Mambatta AK, Alagesan M, Meeran M, Rein JL, Ganesan S, Mathew AC, et al. Evaluation of iron status in patients with end stage renal disease. Int J Adv Med. 2017 Sep 22;4(5):1415-21.

Deori R, Bhuyan B. Iron status in chronic kidney disease patients. Inter J Res Med Sci. 2017 Jan 4; 4(8):3229-34.

Łukaszyk E, Łukaszyk M, Koc-Żórawska E, Tobolczyk J, Bodzenta-Łukaszyk A, Małyszko J. Iron status and inflammation in early stages of chronic kidney disease. Kidney Blood Pressure Res. 2015;40(4):366-73.

Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, et al. The prevalence and management of anemia in chronic kidney disease patients: Result from the korean cohort study for outcomes in patients with chronic kidney disease (know-ckd). J Korean Med Sci. 2017 Feb 1;32(2):249-56.

Reddy GC, Devaki R, Rao P. Iron indices in patients with functional anemia in chronic kidney disease. EJIFCC. 2014 Feb;24(3):129.

Huang MJ, Wei RB, Wang Y, Su TY, Di P, Li QP, et al. Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open. 2017 May 1;7(5):e014294.